EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

In vitro activity of SF001: a next-generation polyene versus amphotericin B

Roya Vahedi-Shahandashti iD, Cornelia Lass-Flörl iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00322-25 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Roya Vahedi-Shahandashti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Tyrol, Austria. Hauptthemen laut MEDLINE: Amphotericin B, Antifungal Agents, Polyenes, Aspergillus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HOROS Doctoral Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SF001, a next-generation polyene drug, offers broad-spectrum fungicidal activity with less potential for toxicity than classic polyene amphotericin B (AmB). This study compared the in vitro activity of SF001 and amphotericin B against Candida and Aspergillus species. SF001 demonstrated activity comparable to AmB against Candida isolates (MIC 50/90 of 0.25/1 and 0.5/0.5 mg/L, respectively). However, Aspergillus isolates exhibited higher susceptibility to SF001 than AmB (MIC 50/90 of 0.5/1 and 1/4 mg/L, respectively), notably including AmB-resistant species.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amphotericin BAntifungal AgentsPolyenesAspergillusCandidaMicrobial Sensitivity TestsHumans

Stichwörter der Autor:innen

amphotericin B resistanceamphotericin B toxicityantifungal resistanceantifungal susceptibility testingantifungal therapyinvasive fungal infections (IFIs)novel antifungal agents

Substanzen

Amphotericin BAntifungal AgentsPolyenes

Autor:innen und Institutionen

  • Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.

ORCID-Profile: Roya Vahedi-Shahandashti, Cornelia Lass-Flörl

Förderung

  • HOROS Doctoral Program

Zitieren

APA

Vahedi-Shahandashti, R., & Lass-Flörl, C. (2025). In vitro activity of SF001: a next-generation polyene versus amphotericin B. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00322-25

Vancouver

Vahedi-Shahandashti R, Lass-Flörl C. In vitro activity of SF001: a next-generation polyene versus amphotericin B. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00322-25

BibTeX
@article{VahediShahandashti2025,
  author = {Vahedi-Shahandashti, Roya and Lass-Flörl, Cornelia},
  title = {In vitro activity of SF001: a next-generation polyene versus amphotericin B},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00322-25}
}
Kostenlos starten →